| mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.011 |
0.9 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.9 |
| mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
0.0082 |
0.9 |
| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.9 |
| mRNA |
serdemetan |
FIMM |
pan-cancer |
AAC |
0.024 |
0.9 |